There is no shortage of studies using 'omic' technologies (genomics, transcriptomics, and proteomics) for studying retinal physiology and pathophysiology. For instance, searching PubMed (http://www.ncbi.nlm.nih.gov/pubmed) for manuscripts using transcriptomics to study glaucoma-relevant biology yielded 71 hits; however, to date, metabolomics has not been widely used to study ocular biology. Metabolomics is a relatively new technology that quantifies the numerous metabolites that make up the metabolome of a given cell or tissue.
